We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $345M
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+34.25%
3 Year Est. Return
+107.36%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$8.72M
Cap. Flow
-$3.69M
Cap. Flow %
-1.39%
Top 10 Hldgs %
52.32%
Holding
59
New
5
Increased
9
Reduced
28
Closed
3

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$5.81M
2
WCIC
WCI Communities, Inc.
WCIC
+$881K
3
MS icon
Morgan Stanley
MS
+$194K
4
AFMD
Affimed
AFMD
+$123K
5
ALGT icon
Allegiant Air
ALGT
+$34.9K

Top Sells

Rank Stock Value
1
NSR
Neustar Inc
NSR
+$7.23M
2
PKW icon
Invesco BuyBack Achievers ETF
PKW
+$4.76M
3
LCI
Lannett Company, Inc.
LCI
+$4.08M
4
GILD icon
Gilead Sciences
GILD
+$203K
5
DSPG
DSP Group Inc
DSPG
+$148K

Sector Composition

Rank Sector Weight
1 Healthcare 30.1%
2 Technology 18.94%
3 Consumer Discretionary 12.06%
4 Financials 9.99%
5 Industrials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFH icon
1
Bread Financial
BFH
$4.22B
$25.8M 9.74%
150,648
-782
-0.5% -$133K
GILD icon
2
Gilead Sciences
GILD
$186B
$17M 6.41%
214,495
-2,505
-1% -$203K
AAPL icon
3
Apple
AAPL
$4.7T
$17M 6.41%
600,444
-2,076
-0.3% -$54.9K
ON icon
4
ON Semiconductor
ON
$28.7B
$15.5M 5.84%
1,255,265
-6,470
-0.5% -$66.9K
MSFT icon
5
Microsoft
MSFT
$3.72T
$13.5M 5.11%
234,738
-800
-0.3% -$45.2K
GLD icon
6
SPDR Gold Trust
GLD
$149B
$10.9M 4.12%
86,715
-605
-0.7% -$77.1K
HBI
7
DELISTED
Hanesbrands
HBI
$10M 3.78%
396,705
-2,450
-0.6% -$64.6K
WCIC
8
DELISTED
WCI Communities, Inc.
WCIC
$9.74M 3.68%
410,495
+47,825
+13% +$881K
BMY icon
9
Bristol-Myers Squibb
BMY
$136B
$9.72M 3.67%
180,316
-1,024
-0.6% -$65.8K
RUSHA icon
10
Rush Enterprises Class A
RUSHA
$5.92B
$9.43M 3.56%
1,299,382
– –
UNH icon
11
UnitedHealth
UNH
$356B
$8.35M 3.15%
59,660
-560
-0.9% -$78.4K
CE icon
12
Celanese
CE
$4.9B
$8.23M 3.11%
123,720
-850
-0.7% -$55.6K
SAVE
13
DELISTED
Spirit Airlines, Inc.
SAVE
$8.13M 3.07%
191,280
-1,275
-0.7% -$52.9K
TEVA icon
14
Teva Pharmaceuticals
TEVA
$42.4B
$8.09M 3.05%
175,770
-885
-0.5% -$46.2K
CELG
15
DELISTED
Celgene Corp
CELG
$7.68M 2.9%
73,515
+53,706
+271% +$5.81M
MCK icon
16
McKesson
MCK
$106B
$7.63M 2.88%
45,753
-430
-0.9% -$80.2K
BIIB icon
17
Biogen
BIIB
$32.6B
$7.35M 2.78%
23,478
-225
-0.9% -$66.6K
LCI
18
DELISTED
Lannett Company, Inc.
LCI
$7.2M 2.72%
67,733
-33,368
-33% -$4.08M
DAL icon
19
Delta Air Lines
DAL
$52.5B
$5.27M 1.99%
134,005
+300
+0.2% +$11.4K
GMLP
20
DELISTED
Golar LNG Partners LP
GMLP
$5.19M 1.96%
264,295
-1,110
-0.4% -$21K
SLB icon
21
SLB Ltd
SLB
$84.8B
$4.72M 1.78%
59,985
-95
-0.2% -$7.54K
ALGT icon
22
Allegiant Air
ALGT
$2.13B
$4.52M 1.71%
34,258
+257
+0.8% +$34.9K
HAL icon
23
Halliburton
HAL
$30.7B
$4.49M 1.7%
100,000
– –
CYH icon
24
Community Health Systems
CYH
$408M
$4.33M 1.64%
375,380
-1,865
-0.5% -$21.5K
OLED icon
25
Universal Display
OLED
$3.78B
$4.18M 1.58%
75,360
+430
+0.6% +$27.3K
1
2 3

Similar funds

BMC
Bear Mountain Capital Seattle, Washington $345M AUM 13.71% 1-Year Est. Return
GSC
G&S Capital Denver, Colorado $345M AUM 32.53% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
LCM
Lonestar Capital Management San Francisco, California $345M AUM 80.24% 1-Year Est. Return
WFI
West Family Investments Carlsbad, California $345M AUM 46.29% 1-Year Est. Return
M2MC
Matthew 25 Management Corp Ambler, Pennsylvania $345M AUM 31.27% 1-Year Est. Return
FRA
Front Row Advisors Tiburon, California $345M AUM 39.04% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $345M AUM 113.04% 1-Year Est. Return

Muhlenkamp & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Muhlenkamp & Co held 59 positions worth $265M, up 3.4% from $256M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Muhlenkamp & Co's Q3 2016 filing shows 5 new, 9 increased, 28 reduced and 3 closed positions. Its largest new stake was Morgan Stanley: 6,505 shares worth $209K. The largest sale was Neustar Inc, an estimated $7.23M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Muhlenkamp & Co's largest Q3 2016 buy was Morgan Stanley: 6,505 shares worth $209K.
  • Muhlenkamp & Co added most to Celgene Corp in Q3 2016, an estimated $5.81M increase.
  • Muhlenkamp & Co's biggest Q3 2016 reduction was Invesco BuyBack Achievers ETF, cutting an estimated $4.76M.
  • Muhlenkamp & Co fully exited Neustar Inc in Q3 2016, selling an estimated $7.23M.
  • Muhlenkamp & Co's ten largest holdings make up 52% of its $265M portfolio in Q3 2016.
  • Muhlenkamp & Co opened 5 new positions and closed 3 in Q3 2016.
  • Muhlenkamp & Co's portfolio value rose 3.4% quarter-over-quarter to $265M.

Based on Muhlenkamp & Co's 13F filing for Q3 2016, filed 14 Nov 2016.